Please login to the form below

Not currently logged in
Email:
Password:

Takeda regains Prostap from Wyeth

Takeda has signed an agreement with Wyeth to regain the product licence to market Prostap in the UK and Republic of Ireland

Takeda has signed an agreement with Wyeth to regain the product licence to market Prostap in the UK and Republic of Ireland.

Under the agreement, marketing authorisation for Prostap, a prostate cancer therapy, would return to the drug's developer, Takeda. The Japanese-owned company signed over the marketing authorisation for the product in the UK and Republic of Ireland to Wyeth in 1990.

Marketing for the entire Prostap product range in the UK and Republic of Ireland will revert to Takeda from July 1, 2009.

"The addition of Prostap will enrich our product portfolio, which currently consists of Amias, Actos and Competact, and is a logical development of our plan to develop a substantial franchise in the oncology market", commented Trevor Smith, Takeda UK's managing director.

Prostap is used for the treatment of prostate cancer, endometrisis and uterine fibroids. It is marketed in around 80 countries and is considered a gold standard therapy for prostate cancer.

26th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics